Related references
Note: Only part of the references are listed.Cardioprotective Effects of Glucagon-like Peptide-1 (9-36) Against Oxidative Injury in H9c2 Cardiomyoblasts: Potential Role of the PI3K/Akt/NOS Pathway
Narawat Nuamnaichati et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2022)
Cardioprotective Effects of Glucagon-like Peptide-1 (9-36) Against Oxidative Injury in H9c2 Cardiomyoblasts: Potential Role of the PI3K/Akt/NOS Pathway
Narawat Nuamnaichati et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2022)
Communication Between Cardiomyocytes and Fibroblasts During Cardiac Ischemia/Reperfusion and Remodeling: Roles of TGF-beta, CTGF, the Renin Angiotensin Axis, and Non-coding RNA Molecules
Raul Flores-Vergara et al.
FRONTIERS IN PHYSIOLOGY (2021)
Angiotensin Type 1 Receptor Blockers in Heart Failure
Khuraijam Dhanachandra Singh et al.
CURRENT DRUG TARGETS (2020)
Stimulation of GLP-1 Receptor Inhibits Methylglyoxal-Induced Mitochondrial Dysfunctions in H9c2 Cardiomyoblasts: Potential Role of Epac/PI3K/Akt Pathway
Narawat Nuamnaichati et al.
FRONTIERS IN PHARMACOLOGY (2020)
Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
Mark Sweeney et al.
EMBO MOLECULAR MEDICINE (2020)
Therapeutic Targets for the Treatment of Cardiac Fibrosis and Cancer: Focusing on TGF-β Signaling
Warisara Parichatikanond et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
TRPC3-Nox2 axis mediates nutritional deficiency-induced cardiomyocyte atrophy
Suhaini Binti Sudi et al.
SCIENTIFIC REPORTS (2019)
Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure
Lauren B. Arendse et al.
PHARMACOLOGICAL REVIEWS (2019)
Sustained β-AR stimulation induces synthesis and secretion of growth factors in cardiac myocytes that affect on cardiac fibroblast activation
Narawat Nuamnaichati et al.
LIFE SCIENCES (2018)
ANGIOTENSIN II SIGNAL TRANSDUCTION: AN UPDATE ON MECHANISMS OF PHYSIOLOGY AND PATHOPHYSIOLOGY
Steven J. Forrester et al.
PHYSIOLOGICAL REVIEWS (2018)
Epac is required for exogenous and endogenous stimulation of adenosine A(2B) receptor for inhibition of angiotensin II-induced collagen synthesis and myofibroblast differentiation
Sarawuth Phosri et al.
PURINERGIC SIGNALLING (2018)
Prolonged stimulation of beta(2)-adrenergic receptor with beta(2)-agonists impairs insulin actions in H9c2 cells
Warisara Parichatikanond et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2018)
Myofibroblasts and inflammatory cells as players of cardiac fibrosis
Hitoshi Kurose et al.
ARCHIVES OF PHARMACAL RESEARCH (2016)
Myocyte-fibroblast communication in cardiac fibrosis and arrhythmias: Mechanisms and model systems
Jason Pellman et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Vascular Endothelial Growth Factor Is Associated with the Morphologic and Functional Parameters in Patients with Hypertrophic Cardiomyopathy
Radek Pudil et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Modulation of angiotensin II signaling in the prevention of fibrosis
Amanda M. Murphy et al.
FIBROGENESIS & TISSUE REPAIR (2015)
Activation of the AT1R/HIF-1α/ACE Axis Mediates Angiotensin II-Induced VEGF Synthesis in Mesenchymal Stem Cells
Chao Liu et al.
BIOMED RESEARCH INTERNATIONAL (2014)
2,3,4′,5-Tetrahydroxystilbene-2-O-β-D-glucoside inhibits angiotensin II-induced cardiac fibroblast proliferation via suppression of the reactive oxygen species-extracellular signal-regulated kinase 1/2 pathway
Wei Zhang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2012)
The endothelium-dependent effect of RTEF-1 in pressure overload cardiac hypertrophy: role of VEGF-B
Ming Xu et al.
CARDIOVASCULAR RESEARCH (2011)
IRF3 regulates cardiac fibrosis but not hypertrophy in mice during angiotensin II-induced hypertension
Kensuke Tsushima et al.
FASEB JOURNAL (2011)
Angiotensin II type 1 receptor blockers: class effects versus molecular effects
Shin-ichiro Miura et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2011)
Connective tissue growth factor induces cardiac hypertrophy through Akt signaling
Nozomi Hayata et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Angiotensin II-induced extracellular signal-regulated kinase 1/2 activation is mediated by protein kinase Cδ and intracellular calcium in adult rat cardiac fibroblasts
Erik R. Olson et al.
HYPERTENSION (2008)
Cardiac fibroblasts influence cardiomyocyte phenotype in vitro
W. A. LaFramboise et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II
L Hunyady et al.
MOLECULAR ENDOCRINOLOGY (2006)
Long-lasting angiotensin type 1 receptor binding and protection by candesartan: comparison with other biphenyl-tetrazole sartans
Georges Vauquelin et al.
JOURNAL OF HYPERTENSION (2006)
Activation of TGF-β1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats
M Matsumoto-Ida et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Role of EGF receptor activation in angiotensin II-induced renal epithelial cell hypertrophy
Jianchun Chen et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Cardiac-specific overexpression of AT1 receptor mutant lacking Gαq/Gαi coupling causes hypertrophy and bradycardia in transgenic mice
PY Zhai et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
TGF-β1 induces cardiac hypertrophic responses via PKC-dependent ATF-2 activation
JY Lim et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Effects of losartan and valsartan on left ventricular hypertrophy and function in essential hypertension
M Picca et al.
ADVANCES IN THERAPY (2004)
Connective-tissue growth factor - a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats
MS Ahmed et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
TGF-β1 and angiotensin networking in cardiac remodeling
S Rosenkranz
CARDIOVASCULAR RESEARCH (2004)
Cardiac hypertrophy: A matter of translation
RD Hannan et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2003)
Gene expression in fibroblasts and fibrosis - Involvement in cardiac hypertrophy
I Manabe et al.
CIRCULATION RESEARCH (2002)
AT1-receptor blockers:: differences that matter
AH Gradman
JOURNAL OF HUMAN HYPERTENSION (2002)
Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension
S Ichihara et al.
CIRCULATION (2001)
Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts
H Kawano et al.
CIRCULATION (2000)
Share Paper
